February 05, 2021

AstraZeneca Covid-19 Vaccine Effective Against U.K. Variant In Trial-The Wall Street Journal

A Covid-19 vaccine developed by the University of Oxford and AstraZeneca PLC is effective against a variant of coronavirus that is spreading rapidly in the U.S. and around the world, according to a new study, a reassuring sign for governments banking on mass vaccination to bring the pandemic to an end. The preliminary findings, published in a study online Friday that hasn’t yet been formally reviewed by other scientists, follow similarly positive results from other manufacturers. The Wall Street Journal, 02/05/2021